Form 4 for LRCX Lam Research
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-02 · accession 0001469469-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-03 | 2026-03-02 | LRCX | Bettinger Douglas R | CFO, EVP | M - OptEx | $51.28 | +66.3K | 1.09M | +6% | +$3.40M |
| D | 2026-03-03 | 2026-03-02 | LRCX | Bettinger Douglas R | CFO, EVP | S - Sale+OE | $230.22 | -40.3K | 1.05M | -4% | -$9.28M |
| DM | 2026-03-03 | 2026-03-02 | LRCX | Bettinger Douglas R | CFO, EVP | M - OptEx | $0.00 | -66.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | M | A | 37,980 | $54.06 | 1,082,631 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Common | Common Stock | 2026-03-02 | M | A | 16,620 | $59.88 | 1,044,651 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 3 | Common | Common Stock | 2026-03-02 | M | A | 11,710 | $30.03 | 1,094,341 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 4 | Common | Common Stock | 2026-03-02 | S | D | 40,329 | $230.22 | 1,054,012 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $230.07 .00 to $230.39, inclusive (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2026-03-02 | M | D | 11,710 | $0.00 | 0 | D | $30.03 · — to 2027-03-02 | 11,710 Common Stock | (F5) The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2026-03-02 | M | D | 37,980 | $0.00 | 0 | D | $54.06 · — to 2029-03-01 | 37,980 Common Stock | (F4) The stock options will become exercisable in three equal installments on 03/01/2023, 03/01/2024 and 03/01/2024. |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2026-03-02 | M | D | 16,620 | $0.00 | 0 | D | $59.88 · — to 2028-03-01 | 16,620 Common Stock | (F3) The stock options will become exercisable in three equal installments on 03/01/2022, 03/01/2023 and 03/01/2024. |